Noul Co.,Ltd. (KOSDAQ:376930)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,987.00
+71.00 (3.71%)
Last updated: Aug 14, 2025
3.71%
Market Cap73.52B
Revenue (ttm)2.97B
Net Income (ttm)-22.87B
Shares Out36.95M
EPS (ttm)-619.26
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume332,135
Average Volume198,542
Open1,916.00
Previous Close1,916.00
Day's Range1,916.00 - 2,010.00
52-Week Range1,820.00 - 3,935.00
Beta-0.66
RSI49.62
Earnings DateAug 14, 2025

About Noul Co.,Ltd.

Noul Co.,Ltd. engages in the in vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, and immunohistochemistry services. Noul Co.,Ltd. was founded in 2015 and is headquartered in Yongin-si, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2015
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 376930
Full Company Profile

Financial Performance

In 2024, Noul Co.,Ltd.'s revenue was 1.60 billion, a decrease of -41.42% compared to the previous year's 2.73 billion. Losses were -22.47 billion, 37.7% more than in 2023.

Financial Statements

News

There is no news available yet.